1. Home
  2. XLO vs IPWR Comparison

XLO vs IPWR Comparison

Compare XLO & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.41

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$3.81

Market Cap

42.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
IPWR
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
39.4M
42.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
XLO
IPWR
Price
$8.41
$3.81
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$28.00
$10.75
AVG Volume (30 Days)
31.3K
115.8K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,766,000.00
N/A
Revenue This Year
N/A
$2,603.56
Revenue Next Year
$168.77
$1,800.00
P/E Ratio
N/A
N/A
Revenue Growth
589.88
N/A
52 Week Low
$0.46
$2.62
52 Week High
$9.25
$6.90

Technical Indicators

Market Signals
Indicator
XLO
IPWR
Relative Strength Index (RSI) 69.92 63.79
Support Level $0.62 $3.77
Resistance Level $9.22 $4.02
Average True Range (ATR) 0.43 0.39
MACD -0.27 0.11
Stochastic Oscillator 29.47 76.55

Price Performance

Historical Comparison
XLO
IPWR

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

About IPWR Ideal Power Inc.

Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: